Science Explorer Back to mapMap
Discussion

NanoCor Therapeutics (United States)

Research works
2
▲ 136% vs 2018-21
Citations
5
2.3 per fractional work
Top-10% rate
0.8%
all institutions 10.0%
Open access
27%
world 40%
International
63%
world 18%
NanoCor Therapeutics (United States)

Not ranked overall: NanoCor Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NanoCor Therapeutics (United States) work in?

In all years, 48% of research at NanoCor Therapeutics (United States) is in Physical Sciences, 48% in Health Sciences. Its largest fields are Medicine (48%), Materials Science (38%), Engineering (10%).

Life Sciences5%Physical Sciences48%Health Sciences48%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Materials Science138.1%
    2. Engineering09.5%
    1. Medicine147.6%
    1. Biochemistry, Genetics and Molecular Biology04.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from NanoCor Therapeutics (United States)?

The most cited paper from NanoCor Therapeutics (United States) is "Effect of Aging on Mineral-Filled Nanocomposites" (A. Ya. Gol'dman, J. A. Montes, Andrés Barajas et al., 1999), with 4 citations. Next come "ID: 324899 A Single-Center, Retrospective Chart Review of 60-day PNS Used for Shoulder Pain" (0) and "ID: 319320 Assessing Multi-Dimensional Improvement Following 60-Day PNS Used for Knee Pain: A Retrospective Review" (0).

Most cited papers
#PaperReleasedCitations
1 Effect of Aging on Mineral-Filled Nanocomposites A. Ya. Gol'dman, J. A. Montes, Andrés Barajas et al. · Elsevier eBooks Book chapter 1999 4
2 ID: 324899 A Single-Center, Retrospective Chart Review of 60-day PNS Used for Shoulder Pain Genaro G. Gutierrez, Pankaj D Mehta, Charles Adam Mouch et al. · Neuromodulation Technology at the Neural Interface Oct 2024 0
3 ID: 319320 Assessing Multi-Dimensional Improvement Following 60-Day PNS Used for Knee Pain: A Retrospective Review David E. Reece, Zachary McCormick, Nirav Niranjan Shah et al. · Neuromodulation Technology at the Neural Interface Oct 2024 0
4 ID: 316674 Retrospective Review of 60-day PNS Treatment Targeting Groin Nerves for Chronic Pain Relief Sepehr Rejai, Harry Sukumaran, Yawar Jamal Qadri et al. · Neuromodulation Technology at the Neural Interface Oct 2024 0
5 ID: 316638 Real-world Outcomes from 60-day PNS Used for Pain in the Cluneal Nerve Distribution: Retrospective Review Stephen A. Erosa, David M. Dickerson, Ivan Urits et al. · Neuromodulation Technology at the Neural Interface Oct 2024 0
All 8 most cited papers, with filters and sorting

Which research topics does NanoCor Therapeutics (United States) publish most on?

By volume in 2022-now: Shoulder Injury and Treatment, Nerve Injury and Rehabilitation, Spine and Intervertebral Disc Pathology and Pain Management and Treatment.

  1. 1 Shoulder Injury and Treatment Surgery 0 works
  2. 2 Nerve Injury and Rehabilitation Surgery 0 works
  3. 3 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
  4. 4 Pain Management and Treatment Anesthesiology and Pain Medicine 0 works
  5. 5 Musculoskeletal pain and rehabilitation Pharmacology 0 works
  6. 6 Medical Imaging and Analysis Biomedical Engineering 0 works
  7. 7 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
  8. 8 Pain Mechanisms and Treatments Physiology 0 works
  9. 9 Peripheral Nerve Disorders Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Shoulder and Clavicle Injuries Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.8%not open73.2%

World: 40% of research is openly available.

with international co-authors62.8%domestic only37.2%

World: 18% is written across borders.

How has NanoCor Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 136% higher than in 2018-2021.

20002005201020152020

Other research institutions in Chapel Hill

All research institutions in Chapel Hill

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NanoCor Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.